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Abstract
Introduction: The efficacy of management of chronic cough in adults is limited. Speech therapy is one of the few therapeutic 
methods which seems to be useful in patients with persistent chronic cough. However, the method has not been available in 
Poland so far. The aim of the study was to implement speech therapy and assess its efficacy in the management of patients with 
difficult-to-treat chronic cough.
Material and methods: Patients, who were diagnosed and managed due to difficult-to-treat chronic cough, were enrolled into 
the study. Speech therapy was developed on the basis of the technique described by Vertigan. The entire therapy consisted of 
eight weekly sessions, each lasting 45 minutes. Before and after speech therapy, cough severity and its impact on the quality of 
life was assessed by the Visual Analogue Scale (VAS) and Leicester Cough Questionnaire (LCQ). Additionally, cough challenge 
test with capsaicin was performed. 
Results: Eighteen women were enrolled into the study, 15 of them (83%) attended all treatment sessions (median age 66 years, 
median duration of cough 60 months). There was a significant decrease in cough severity measured by VAS (46 vs 28 mm, p = 
0.016) after completion of speech therapy. A significant improvement in patients’ quality of life measured by LCQ (10.7 vs 14.6 
points, p = 0.004) and an increase in the threshold of cough reflex measured by capsaicin challenge were also demonstrated.
Conclusions: Speech therapy resulted in a decrease in cough severity and improvement of quality of life of females with refrac-
tory chronic cough. Our results support the use of speech therapy as add-on treatment in females with difficult-to-treat cough. 
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Introduction
Chronic cough is a common complaint affec-
ting as many as 10–20% of adult population [1–3]. 
It has a negative impact on general health status, 
including physical, psychological and social do-
mains of quality of life [2]. According to a cross 
sectional European survey, 93% of patients with 
chronic cough sought medical attention and 72% 
of patients attended more than three visits becau-
se of this symptom [4]. Therefore, chronic cough 
and its management are related with a significant 
economic burden [2].
Chronic cough is commonly a symptom of 
smoking-related bronchitis. As smokers still acco-
unt for a significant proportion of the adult popu-
lation in Poland (30% of men and 21% of women), 
smoking related bronchitis is a frequent cause of 
cough in our country [5]. However, smokers rarely 
seek medical advice because of cough. The most 
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common causes of chronic cough in non-smoking 
adults with a normal chest radiograph are: upper 
airway cough syndrome (UACS) i.e. chronic rhi-
nitis or rhinosinusitis; gastroesophageal reflux 
disease (GERD); asthma and non-asthmatic eosi-
nophilic bronchitis (NAEB) and treatment with 
ACE inhibitors. In many patients cough may have 
two or more coexisting causes [1–3]. Our previous 
study showed that 42.5% of patients with chronic 
cough had a single underlying disease, while 45% 
and 12.5% of patients were diagnosed with two 
and three coexisting causes, respectively [6]. In 
the majority of patients chronic cough can be 
successfully diagnosed and treated, but in 5–10% 
cough persists, despite a thorough diagnostic and 
therapeutic work-up [7]. In specialized cough 
clinics, the proportion of patients with persistent, 
difficult-to-treat cough is even higher. The gro-
up of patients with persistent cough includes 
both patients with unexplained chronic cough 
(of unknown cause or cough with inconclusive 
diagnostic work-up) and difficult-to-treat cough 
(chronic cough with known underlying cause(s) 
which failed to respond to specific treatment) [7]. 
Unexplained and difficult-to-treat chronic cough 
significantly impairs patients’ quality of life [7–9], 
nevertheless the number of therapeutic options 
that can be effectively applied in such patients 
is very limited. These include pharmacotherapy 
with gabapentin, pregabalin or baclofen and 
non-pharmacological intervention called speech 
and language or voice therapy [7, 10]. The latter 
consists of education, respiratory and speech 
exercises and teaching the strategies to reduce 
cough [10, 11]. The results of recent studies 
suggest that speech therapy might be useful in 
the management of persistent, refractory cough 
[12–14]. However, this method has not been ava-
ilable in Poland to date. 
Therefore, the aim of this study was to deve-
lop and implement our own protocol of speech 
therapy and to assess its efficacy in the treatment 
of patients with difficult-to-treat or unexplained 
chronic cough.
Materials and methods
Study design
This was a prospective, single arm, single 
center study performed between 2015 and 2017. 
The study was registered at ClinicalTrials.gov 
(NCT 03457610). The protocol of the study was 
approved by the Institutional Review Board of the 
Medical University of Warsaw (KB/218/2015) and 
all enrolled patients signed an informed consent.
Patients 
The study group was recruited from patients 
diagnosed and treated due to chronic cough in 
the Department of Internal Medicine, Pulmonary 
Diseases and Allergy of the Medical University of 
Warsaw. As there was a significant female predo-
minance in our cohort of patients with chronic 
cough, we decided to enroll only women. The 
remaining inclusion criteria were as follows: 1) 
age between 18 and 80 years, 2) chronic cough 
lasting more than six months, 3) unsuccessful 
management of cough despite at least 3-month 
treatment, 4) no symptoms of acute airway infec-
tion in the previous 4 weeks preceding the study. 
The main exclusion criteria were: 1) inability to 
participate in speech therapy sessions, 2) cough 
lasting less than 6 months, 3) active cigarette 
smoking, 4) current therapy with ACE inhibitors, 
5) symptoms of acute airway infection (other than 
cough), and 6) abnormal chest radiogram or CT 
scan suggesting any acute or chronic pulmonary 
disorder (including infection, neoplasm or inter-
stitial lung disease). In all patients, a panel of the 
diagnostic procedures was applied to diagnose 
the cause of chronic cough. These included: spi-
rometry with bronchial obstruction reversibility 
testing, methacholine challenge, induced sputum 
analysis, computed tomography of the chest and 
paranasal sinuses, multichannel/pH impedance 
and ENT assessment. Then, an appropriate tre-
atment concordant with the causative diagnosis 
was applied. Patients who failed to respond to 
treatment or patients with unexplained chronic 
cough were offered speech therapy in the frame 
of the current study. The patients could continue 
their earlier treatment of cough but no new thera-
pies other than speech were allowed at this point. 
Speech therapy
Speech therapy was conducted using a pro-
tocol developed by our team on the basis of the 
technique described by Vertigan et al. [11, 12, 15]. 
It started with patient education on the pathophy-
siology of chronic cough with emphasis on the 
lack of benefit of repeated coughing, its harmful 
effects on the larynx and airways and the advanta-
ges of voluntary cough suppression. The patients 
were informed on the significance of their poten-
tial to voluntarily control the cough. Additionally, 
cough triggers and specific techniques to suppress 
the cough and avoid laryngeal irritation were 
presented. Speech therapy included breathing 
exercises (nose and pursed lip breathing), swal-
lowing exercises (dry swallows or with sip of 
water, chewing gum or sucking candies in order 
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to swallow saliva more frequently and attempt to 
delay the cough) and vocal exercises. Moreover, 
vocal hygiene was implemented to maximize hy-
dration and reduce larynx irritation. It included 
increase of water intake and avoiding exposure 
to environmental smoking or substances known 
to have drying effect on the larynx (caffeine, al-
cohol). The effectiveness of the interventions was 
monitored during the entire therapy. The therapy 
consisted of eight weekly sessions (2 individual 
and 6 group sessions), each lasting 45 minutes. 
After each session the patients were encouraged 
to repeat the exercises at home. 
Assessment of treatment efficacy 
Before and after speech therapy, cough seve-
rity and its impact on the quality of life were as-
sessed by the Visual Analogue Scale (VAS; range 
0–100 mm) and Leicester Cough Questionnaire 
(LCQ; range 3–21 points), in accordance with ERS 
recommendations. The higher numbers in the 
visual analogue cough scale reflected more severe 
cough, while the higher LCQ value corresponded 
with better quality of life in patients with cough. 
A validated Polish version of the LCQ was used [16]. 
The minimal clinically important difference 
(MCID) for LCQ total score is 1.3 points; there is 
no validated value of MCID for VAS in chronic 
cough [17–19]. 
Besides VAS and LCQ, cough challenge test 
with capsaicin was performed before and after the-
rapy to assess the sensitivity to inhaled irritants 
expressed by C2 and C5 (concentration of capsa-
icin which induces 2 and 5 coughs during chal-
lenge test with capsaicin, respectively) [17, 18]. 
Finally, the patients were asked to answer three 
questions on their subjective rating of the effect 
of speech therapy (complete vs partial vs no 
response) and the appraisal of the usefulness of 
each part of speech therapy. Complete response 
was defined as complete cough resolution, par-
tial response as decreased cough severity and no 
response as no change in cough severity before 
and after speech therapy.
Statistical analysis
Statistical analysis was performed with Stati-
stica 13.1 (StatSoft, Tulsa, USA) software package. 
Data on patient characteristics were presented 
as median and interquartile range (IQR) unless 
otherwise specified. Differences between conti-
nuous variables measured before and after speech 
therapy were analyzed by Wilcoxon test. All p-va-
lues were 2-tailed and p < 0.05 was considered 
statistically significant.
Results
Eighteen patients were initially enrolled. 
Fifteen (83%) attended all speech therapy ses-
sions and thus completed the whole treatment 
program. Only those patients were included in 
the final analysis. Of the 3 patients who failed to 
complete the program, two were excluded becau-
se of irregular attendance to the sessions and one 
due to acute upper airway infection. The detailed 
characteristics of the study group are presented 
in Table 1. All patients were nonsmoking women, 
median age 66 years with median duration of 
cough 60 months. 
After 8 weeks of speech therapy, a signifi-
cant decrease in cough severity measured by 
VAS (46 vs 28 mm, p = 0.016) and significant 
improvement in patients’ quality of life measu-
red by LCQ (10.7 vs 14.6 points, p = 0.004) were 
noted (Table 2). Clinically important increase 
(> 1.3 points) in total LCQ score was demon-
strated in as many as 13/15 (87%) patients. The 
sensitivity of cough reflex measured by capsa-
icin challenge test was lower, but the result was 
significant only for C2 (Table 2). The increase 
in cough reflex threshold measured as C2 and 
C5 was found in 8 (53%) and 9 (60%) patients, 
respectively (Fig. 1). 
After completion of the speech therapy pro-
gram, one patient declared complete response, 
while all the remaining (14/15) declared partial 
improvement. All patients declared that breathing 
exercises were the most useful component of 
speech therapy.
Table 1 . Baseline demographic and clinical characteri-
stics of the study group 
Patients 
n = 15
Age, years 66 (56–71)
Sex F/M 15/0
Smoking history S/EX/NS 0/2/13
Cough duration, months 60 (42–156)
BMI, kg/m2 26.2 (23.1–28.7)
Cough causes, number of pts.
    GERD
    UACS
    Asthma
    Other causes
UCC 
10
6
4
1
1
Data are given as median and IQR (in parenthesis) or number of patients. BMI: 
body mass index; EX: ex-smoker; F: female; GERD: gastroesophageal reflux 
disease; M: male; NS: never smoker; S: smoker; UACS: upper airway cough 
syndrome; UCC: unexplained chronic cough
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Table 2. Results of the speech therapy
Before 
speech therapy
After 
speech therapy
p–value
Severity of cough 
measured by VAS, mm
46
(38.5–73)
28
(21.5–65)
0.016
Quality of life measured by LCQ, points
 LCQ physical domain
 LCQ phsychological domain
 LCQ social domain
10.7 (8.4–11.9)
3.62 (3.2–4.1)
3.57 (2.4–4)
3.5 (2.7–3.7)
14.6 (11.9–17.1)
4.75 (4.3–5.4)
4.87(4–6.1)
5.0 (3.6–5.7)
0.004
0.001
0.004
0.009
Sensitivity of cough reflex
measured by capsaicin challenge, µM
C2–1.96
(0.98 –7.84)
C5 –3.92 
(1.96–15.68)
C2–3.92
(1.96 –15.68)
C5 –7,84 
(3.92–78.4)
0.03
> 0.05
Data are given as median and IQR (in parenthesis). The effect of speech therapy was analysed using Wilcoxon test. C2: concentration of capsaicin, which induces 
2 coughs; C5: concentration of capsaicin, which induces 5 coughs; LCQ: Leicester Cough Questionnaire, range 3–21 points; VAS: visual analogue scale, range 0–100 mm
Figure 1. Effect of speech therapy on results of capsaicin cough challenge test. C2: concentration of capsaicin, which induces 2 coughs; C5: con-
centration of capsaicin, which induces 5 coughs 
Discussion
The results of our study demonstrated that 
speech therapy based on the methods described by 
Vertigan et al. [11, 12, 15] was an effective thera-
peutic approach for patients (in our group women) 
with persistent, difficult-to-treat cough. Speech 
therapy significantly reduced cough severity and 
improved patients’ quality of life. These results 
are particularly important in the context of the Eu-
ropean Respiratory Society (ERS) and American 
College of Chest Physicians (ACCP) guidelines 
which state that the above parameters measure 
the most important aspects of cough assessment 
[17, 18]. It should also be emphasized that all our 
patients showed partial or complete response to 
applied therapy.
We would like to stress that the favorable 
results were obtained in patients who had been 
unsuccessfully treated for a long time before the 
study onset. The median duration of cough in this 
group was 60 months, but the longest duration 
was 30 years. Only one patient diagnosed with 
unexplained chronic cough had not received cau-
sative treatment before the study onset. Failure 
in management of chronic cough is a well-known 
phenomenon [7, 20]. In previous studies, 36–55% 
of patients with known cause of chronic cough 
did not respond to specific therapy [4, 20, 21]. 
According to the ACCP guidelines, persistent 
untreatable cough affects approximately 5–10% 
of all patients with chronic cough and even up 
to 46% of patients managed in specialized cough 
clinics [7]. It seems that the failure of cough tre-
atment may result from hypersensitivity of cough 
reflex [7, 20, 22]. It is hypothesized that repeated 
coughing causes laryngeal injury, resulting in 
neural inflammation, increased expression of 
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cough receptors and both peripheral and central 
neuromodulation. Subsequently, cough threshold 
decreases producing cough even with low level 
irritant stimuli. Repeated cough maintains the 
pathophysiological processes in the airways and 
nervous system resulting in difficult-to-treat or 
refractory cough, currently referred to as cough 
hypersensitivity syndrome.
Another important feature of our study group 
was the fact that all patients were women. Similar 
to other authors, we observed a higher prevalence 
of women among patients with chronic cough. In 
international surveys, women accounted for ap-
proximately 67% of population with chronic co-
ugh [20, 21]. It may result from higher sensitivity 
of cough reflex observed in females [20]. Although 
in clinical practice we also see men with chronic 
cough, the predominance of women is highly si-
gnificant. Therefore, we decided to include only 
females to our study. This approach also made our 
study group quite homogenous. Nevertheless, our 
team is also currently working on a study in men, 
and we believe it will be interesting to compare 
the results obtained in women and men. 
 We believe it is critically important to use 
various, possibly the most objective and recom-
mended tools measuring cough in both clinical 
trials and routine practice. Cough severity combi-
nes aspects of cough intensity (measured by VAS), 
frequency (by cough recorders) and influence of 
cough on quality of life (assessed by dedicated 
questionnaires). One of the most common cough 
questionnaire is LCQ, which had recently been 
validated in the Polish population [16]. Following 
the recommendations [17, 18], we implemented 
the measurements of both cough severity and its 
impact on patients’ quality of life. This approach 
enabled more objective assessment of the thera-
peutic efficacy. We also assessed cough intensity 
by cough reflex measurement using capsaicin 
cough challenge test. Although we observed an 
increase in the cough reflex threshold in more 
than one half of patients, the results were so-
mewhat ambiguous. Similar results were recently 
reported by Chamberlain Mitchell et al. [14], 
who confirmed the efficacy of speech and langu-
age intervention in treating chronic cough, but 
did not observe an increase in cough inducing 
capsaicin concentration. It can be speculated 
that in refractory cough, different receptors or 
signaling pathways may be involved than in that 
stimulated by capsaicin. According to the ERS 
and ACCP recommendations, the capsaicin test 
might be useful in measuring cough intensity, but 
its use is not mandatory [17, 18, 20]. Although 
cough recorders are recommended for objective 
cough frequency measurement, they are not easily 
available and we did not have access to this tool 
during the study [17, 18]. Therefore, we based on 
subjective tools for cough assessment.
Management of difficult-to-treat chronic 
cough is certainly a challenge and there are only 
two potentially successful methods: pharmaco-
logical — based on centrally acting neuromo-
dulators such as gabapentin or pregabalin and 
nonpharmacological intervention — such as 
speech and language therapy [7, 10]. The latter 
was adapted from the treatment of hyperfunc-
tional voice disorders. Although the first studies 
on speech therapy as a method of chronic cough 
treatment had been published 30 years ago, the 
first randomized trial was reported by Vertigan 
et al. [12] only in 2006. Speech therapy relies on 
multifactorial interventions, which may comprise 
several elements: education on cough, identifica-
tion of cough triggers, teaching cough suppression 
techniques, breathing exercises, vocal hygiene 
and hydration techniques. Sometimes additional 
forms of counselling are used. According to the 
literature, speech therapy is usually delivered by 
speech and language therapists or physiothera-
pists and consists of 2–4 sessions [10–15]. In our 
study, speech therapy was implemented and per-
formed by a phoniatrician (DR) and speech and 
language therapist (AŁ). The mechanism of cough 
reduction by speech intervention is still a matter 
of debate. Perhaps, breathing exercises allow to re-
lax the throat, neck, and shoulder muscles, what 
helps to reduce the adductor activity of the vocal 
folds during expiration in patients with chronic 
cough and paradoxical vocal cord movement 
[10, 15]. Moreover, it is believed that swallows 
may interfere with cough and alter its threshold. 
Similarly, proper hydration and avoidance of la-
ryngeal irritants, as well as conscious suppression 
of cough may desensitize cough reflex, increase 
its threshold and reduce cough frequency. 
To our knowledge, there were only a few stu-
dies on the effect of speech therapy in the manage-
ment of chronic cough [12–14, 23, 24]. All of them 
confirmed the efficacy of speech intervention. The 
recently published randomized multicenter trial 
also confirmed that physiotherapy combined with 
speech and language intervention is an effective 
method of reducing cough in patients with re-
fractory chronic cough [14]. Therefore it was so 
important for us to implement that technique and 
assess its efficacy in Polish population, since such 
a therapeutic approach had not been commonly 
used in Poland before. To our knowledge there has 
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been only one case report published so far, which 
referred to trial of speech therapy in management 
of difficult-to-treat chronic cough in Poland [25].
Although our protocol of speech therapy 
intervention in chronic cough was mainly based 
on that presented by Vertigan et al. [11,12,15], we 
also introduced some modifications. The main 
components of our therapy were education on 
cough pathophysiology and vocal hygiene, iden-
tification of cough triggers, instruction on cough 
suppression techniques, conscious breathing, 
diaphragmatic breathing, relaxed breathing con-
trol techniques, speech and vocal exercises. In-
dividual sessions followed by group sessions was 
our concept of providing patient psychological 
support. The patients were strongly encouraged 
to repeat the exercises at home.
Our study has some limitations. The most 
relevant is the small study group. However, we 
would like to emphasize that these are only pre-
liminary results, which need to be confirmed in 
a larger study. On the other hand, in a recently 
published multicenter randomized control trial 
concerning speech and language intervention, 
there were only 75 patients enrolled and 34 of 
them were allocated to the speech and language 
therapy arm [14]. Therefore, as speech therapy 
had not been available in Poland, our intention 
was to sum up the preliminary results and to 
present the technique. Second, our study inc-
luded only women, and this can be considered 
a selection bias that could have influenced the 
results. On the other hand, persistent, difficult- 
-to-treat cough is more common in women. In 
other similar studies women accounted for even 
68–74% of the study population [12, 14]. Regard-
less of the above, this method certainly needs to 
be evaluated in men with difficult-to-treat cough. 
Third, this study was a single arm, observational 
study without control group or randomization, 
so the results cannot be compared with other 
interventions and control patients. Fourth, the 
effect of speech therapy was measured only once, 
just after the end of the intervention. Therefore, 
there is no evidence that these favorable results 
are long-term. Finally, we did not use cough mo-
nitors to assess the frequency of chronic cough. 
There is no doubt that cough monitors are useful 
for objective measurement of cough frequency 
which significantly increase the reliability of 
studies on cough. However, we have implied all 
other accessible tools to evaluate the impact of 
speech therapy on cough intensity. Despite all 
these limitations, the results of this study seem to 
indicate that speech therapy is a useful technique 
in the management of patients (in our group wo-
men) with difficult-to-treat chronic cough.
Conclusion
Basing on the method described by Vertigan 
et al. [11,12,15], we developed, implemented 
and evaluated speech therapy which resulted in 
a decrease in cough severity and improvement of 
quality of life of patients with refractory chronic 
cough. Our results support the use of speech 
therapy as add-on treatment in females with dif-
ficult-to-treat cough. 
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